4//SEC Filing
Lee Sung 4
Accession 0001127602-25-009770
CIK 0001061983other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:24 PM ET
Size
9.5 KB
Accession
0001127602-25-009770
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
Lee Sung
EVP, Chief Financial Officer
Transactions
- Award
Incentive Stock Option (Right to Buy)
2025-03-14+9,016→ 9,016 totalExercise: $44.36From: 2025-04-14Exp: 2035-03-13→ Common Stock (9,016 underlying) - Award
Common Stock
2025-03-14+32,687→ 74,442 total - Award
Non-Qualified Stock Option (Right to Buy)
2025-03-14+41,326→ 41,326 totalExercise: $44.36From: 2025-04-14Exp: 2035-03-13→ Common Stock (41,326 underlying)
Footnotes (3)
- [F1]Comprised of restricted stock units that convert to shares of common stock on a 1:1 basis upon vesting. 40% of the RSUs will vest on the 1-year anniversary of the date of grant; an additional 40% of the RSUs will vest on the 2-year anniversary of the date of grant; and the final 20% of the RSUs will vest on the 3-year anniversary of the date of grant, in each case subject to Mr. Lee's continued employment with the company on the scheduled vesting date.
- [F2]Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Lee's continued employment with the company on the scheduled vesting date.
- [F3]Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Lee's continued employment with the company on the scheduled vesting date.
Documents
Issuer
CYTOKINETICS INC
CIK 0001061983
Entity typeother
Related Parties
1- filerCIK 0001793200
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:24 PM ET
- Size
- 9.5 KB